BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 33672349)

  • 1. Integrase-Defective Lentiviral Vector Is an Efficient Vaccine Platform for Cancer Immunotherapy.
    Morante V; Borghi M; Farina I; Michelini Z; Grasso F; Gallinaro A; Cecchetti S; Di Virgilio A; Canitano A; Pirillo MF; Bona R; Cara A; Negri D
    Viruses; 2021 Feb; 13(2):. PubMed ID: 33672349
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Successful therapeutic vaccination with integrase defective lentiviral vector expressing nononcogenic human papillomavirus E7 protein.
    Grasso F; Negri DR; Mochi S; Rossi A; Cesolini A; Giovannelli A; Chiantore MV; Leone P; Giorgi C; Cara A
    Int J Cancer; 2013 Jan; 132(2):335-44. PubMed ID: 22700466
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Integrase Defective Lentiviral Vector as a Vaccine Platform for Delivering Influenza Antigens.
    Gallinaro A; Borghi M; Bona R; Grasso F; Calzoletti L; Palladino L; Cecchetti S; Vescio MF; Macchia D; Morante V; Canitano A; Temperton N; Castrucci MR; Salvatore M; Michelini Z; Cara A; Negri D
    Front Immunol; 2018; 9():171. PubMed ID: 29459873
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Integrase-defective lentiviral-vector-based vaccine: a new vector for induction of T cell immunity.
    Negri DR; Michelini Z; Bona R; Blasi M; Filati P; Leone P; Rossi A; Franco M; Cara A
    Expert Opin Biol Ther; 2011 Jun; 11(6):739-50. PubMed ID: 21434847
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dendritic cell-based genetic immunization in mice with a recombinant adenovirus encoding murine TRP2 induces effective anti-melanoma immunity.
    Tüting T; Steitz J; Brück J; Gambotto A; Steinbrink K; DeLeo AB; Robbins P; Knop J; Enk AH
    J Gene Med; 1999; 1(6):400-6. PubMed ID: 10753065
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Optimization of mucosal responses after intramuscular immunization with integrase defective lentiviral vector.
    Rossi A; Michelini Z; Leone P; Borghi M; Blasi M; Bona R; Spada M; Grasso F; Gugliotta A; Klotman ME; Cara A; Negri D
    PLoS One; 2014; 9(9):e107377. PubMed ID: 25210766
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lentivirus-induced 'Smart' dendritic cells: Pharmacodynamics and GMP-compliant production for immunotherapy against TRP2-positive melanoma.
    Sundarasetty BS; Chan L; Darling D; Giunti G; Farzaneh F; Schenck F; Naundorf S; Kuehlcke K; Ruggiero E; Schmidt M; von Kalle C; Rothe M; Hoon DS; Gerasch L; Figueiredo C; Koehl U; Blasczyk R; Gutzmer R; Stripecke R
    Gene Ther; 2015 Sep; 22(9):707-20. PubMed ID: 25965393
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Alphavirus replicon particles expressing TRP-2 provide potent therapeutic effect on melanoma through activation of humoral and cellular immunity.
    Avogadri F; Merghoub T; Maughan MF; Hirschhorn-Cymerman D; Morris J; Ritter E; Olmsted R; Houghton AN; Wolchok JD
    PLoS One; 2010 Sep; 5(9):. PubMed ID: 20844763
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hepatocyte-targeted expression by integrase-defective lentiviral vectors induces antigen-specific tolerance in mice with low genotoxic risk.
    Mátrai J; Cantore A; Bartholomae CC; Annoni A; Wang W; Acosta-Sanchez A; Samara-Kuko E; De Waele L; Ma L; Genovese P; Damo M; Arens A; Goudy K; Nichols TC; von Kalle C; L Chuah MK; Roncarolo MG; Schmidt M; Vandendriessche T; Naldini L
    Hepatology; 2011 May; 53(5):1696-707. PubMed ID: 21520180
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Vaccines delivered by integration-deficient lentiviral vectors targeting dendritic cells induces strong antigen-specific immunity.
    Hu B; Dai B; Wang P
    Vaccine; 2010 Sep; 28(41):6675-83. PubMed ID: 20709004
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Altered intracellular sorting signals do not influence the efficacy of genetic melanoma vaccines incorporating helper determinants in mice.
    Brück J; Steitz J; Strand D; Tüting T
    J Gene Med; 2005 May; 7(5):613-20. PubMed ID: 15580620
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Improving the Transduction of Bone Marrow-Derived Cells with an Integrase-Defective Lentiviral Vector.
    Pay SL; Qi X; Willard JF; Godoy J; Sankhavaram K; Horton R; Mitter SK; Quigley JL; Chang LJ; Grant MB; Boulton ME
    Hum Gene Ther Methods; 2018 Feb; 29(1):44-59. PubMed ID: 29160102
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Integrase-defective lentiviral vectors as a delivery platform for targeted modification of adenosine deaminase locus.
    Joglekar AV; Hollis RP; Kuftinec G; Senadheera S; Chan R; Kohn DB
    Mol Ther; 2013 Sep; 21(9):1705-17. PubMed ID: 23857176
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Vesicular stomatitis virus as a novel cancer vaccine vector to prime antitumor immunity amenable to rapid boosting with adenovirus.
    Bridle BW; Boudreau JE; Lichty BD; Brunellière J; Stephenson K; Koshy S; Bramson JL; Wan Y
    Mol Ther; 2009 Oct; 17(10):1814-21. PubMed ID: 19603003
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Integrase Defective Lentiviral Vector Promoter Impacts Transgene Expression in Target Cells and Magnitude of Vector-Induced Immune Responses.
    Mahesh S; Li J; Travieso T; Psaradelli D; Negri D; Klotman M; Cara A; Blasi M
    Viruses; 2023 Nov; 15(11):. PubMed ID: 38005931
    [TBL] [Abstract][Full Text] [Related]  

  • 16. One-year follow-up of transgene expression by integrase-defective lentiviral vectors and their therapeutic potential in spinocerebellar ataxia model mice.
    Saida H; Matsuzaki Y; Takayama K; Iizuka A; Konno A; Yanagi S; Hirai H
    Gene Ther; 2014 Sep; 21(9):820-7. PubMed ID: 24989813
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dendritic cell-directed lentivector vaccine induces antigen-specific immune responses against murine melanoma.
    Yang HG; Hu BL; Xiao L; Wang P
    Cancer Gene Ther; 2011 May; 18(5):370-80. PubMed ID: 21372855
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Optimal epitope composition after antigen screening using a live bacterial delivery vector: application to TRP-2.
    Derouazi M; Wang Y; Marlu R; Epaulard O; Mayol JF; Pasqual N; Le Gouellec A; Polack B; Toussaint B
    Bioeng Bugs; 2010; 1(1):51-60. PubMed ID: 21327126
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Integrase-Defective Lentiviral Vectors for Delivery of Monoclonal Antibodies against Influenza.
    Michelini Z; Minkoff JM; Yang J; Negri D; Cara A; Hanson BJ; Salvatore M
    Viruses; 2020 Dec; 12(12):. PubMed ID: 33348840
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mucosal immunization with integrase-defective lentiviral vectors protects against influenza virus challenge in mice.
    Fontana JM; Christos PJ; Michelini Z; Negri D; Cara A; Salvatore M
    PLoS One; 2014; 9(5):e97270. PubMed ID: 24824623
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.